Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Visintainer

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Pharmacology|January 19, 2024
A minimal PBPK model to accelerate preclinical development of drugs against tuberculosisFederico Reali, Anna Fochesato, Chanchala Kaddi, et al.
The AAPS Journal|April 7, 2026
Predicting Aberrant Fc-fusion Protein Pharmacokinetics from In Silico Structural Properties and Physiologically Based Pharmacokinetic (PBPK) ModelingDanilo Tomasoni, Alessio Paris, Roberto Visintainer, et al.
Nature Biotechnology|August 25, 2014
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundanceCharles Wang, Binsheng Gong, Pierre R Bushel, et al.
Nature Biotechnology|August 3, 2010
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive modelsLeming Shi, Gregory Campbell, Wendell D Jones, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Pharmacology|January 19, 2024
A minimal PBPK model to accelerate preclinical development of drugs against tuberculosisFederico Reali, Anna Fochesato, Chanchala Kaddi, et al.
The AAPS Journal|April 7, 2026
Predicting Aberrant Fc-fusion Protein Pharmacokinetics from In Silico Structural Properties and Physiologically Based Pharmacokinetic (PBPK) ModelingDanilo Tomasoni, Alessio Paris, Roberto Visintainer, et al.
Nature Biotechnology|August 25, 2014
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundanceCharles Wang, Binsheng Gong, Pierre R Bushel, et al.
Nature Biotechnology|August 3, 2010
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive modelsLeming Shi, Gregory Campbell, Wendell D Jones, et al.
Pageof 2